Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
UFP Technologies, Inc.
UFPT
NASDAQ·Healthcare·Medical - Devices·Mkt cap $2.1B
$268.06
▼ -0.23%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$173.86 - $275.20
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 9.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized expertise in foam, film, and plastic material science with 60+ year track record
- Custom manufacturing capabilities enabling high-barrier entry for competitors
- Established relationships with major medical device OEMs and long-term supply contracts
- Diversified customer base across medical, aerospace, defense, and industrial markets reduces concentration risk
Bear Case
2 risks
- Average volatility.
- Significant premium - growth priced in
Growth
Stable outlook
Rising demand for single-use medical devices driven by infection control and patient safety regulations
Value
Significant premium - growth priced in
Momentum
Hot
+39.9% over 3m
Quality
Stable
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying UFPT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 5, 2026
MAY 4, 2026
Reported EPS of $2.27 vs $2.18 consensus (+4.1% surprise). Revenue of $154.2M vs $154.8M expected (-0.4%).
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+4.1%
Next: May 5, 2026
Revenue trend · last 8Q
—
—
+42%
+41%
+37%
+6%
+3%
+4%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$110.2M
$145.2M
$144.1M
$148.1M
$151.2M
$154.6M
$148.9M
$154.2M
Margins · last 8Q
Gross
—
Operating
—
Profit
11.3%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
No analyst coverage on file for this stock yet.